Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma.
Mweempwa A, Xu H, Vissers JHA, Tothill RW, Pattison AD, Fellowes AP, Thomas DM, Richardson G, Hicks RJ, Grimmond SM, Fox SB, Luen SJ, Desai J, Solomon BJ.
Mweempwa A, et al. Among authors: hicks rj.
JCO Precis Oncol. 2021 Nov;5:1160-1165. doi: 10.1200/PO.21.00127.
JCO Precis Oncol. 2021.
PMID: 34994633
No abstract available.